Showing results (381-390 of 400) with videos related to
Sort By:
Pageof 40
Cancer Research|June 1, 1992
Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effectsC H Ewel, W J Urba, W C Kopp, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1992
Immunoregulation in cancer-bearing hosts. Down-regulation of gene expression and cytotoxic function in CD8+ T cellsC M Loeffler, M J Smyth, D L Longo, et al.The New England Journal of Medicine|March 18, 1993
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatinJ W Smith, D L Longo, W G Alvord, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID)W J Murphy, S K Durum, M R Anver, et al.Journal of the National Cancer Institute|June 5, 1996
Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonucleaseS M Rybak, J W Pearson, W E Fogler, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|March 1, 1996
Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancerB D Curti, W J Urba, D L Longo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's diseaseD L Longo, E Glatstein, P L Duffey, et al.Blood|March 27, 2001
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinomaJ E Janik, L L Miller, E L Korn, et al.Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancerB L Gause, M Sznol, W C Kopp, et al.Pageof 40